Skip to main content
. 2011 Apr 28;17(16):2109–2112. doi: 10.3748/wjg.v17.i16.2109

Table 2.

Clinicopathological variables of serum matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in patients

Variables MMP-1 TIMP-1 P
Lymphovascular invasion
Negative 543 (500-678) 489 (450-573)
Positive 801 (768-845) 642 (567-703) < 0.001
Tumor size (cm)
< 4 478 (460-501) 429 (425-479)
≥ 4 675 (509-725) 671 (532-690) < 0.001
Lymph node metastasis
Negative 563 (503-650) 642 (598-709)
Positive 742 (657-799) 756 (570-876) < 0.001
T stage
T0-2 521 (498-599) 598 (564-783)
T3-4 674 (578-783) 749 (570-794) < 0.001
TNM stage
 I 469 (458-502) 476 (423-512)
II 534 (467-563) 521 (478-589)
III 714 (546-857) 753 (512-699) < 0.001
IV 765 (699-900) 975 (812-1134) < 0.001

MMP-1: Matrix metalloproteinase-1; TIMP-1: Tissue inhibitor of metalloproteinase-1.